Oxford Pharmaceuticals, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 301 Leaf Lake Parkway, Birmingham, Alabama (AL) 35211, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3012257735 · DUNS 079638266
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-11-03
- NAIBioresearch Monitoring2022-06-08
- VAIDrug Quality Assurance2019-05-22
Drugs this plant is listed as making
13 distinct drugs across 35 products name this site in their FDA label.
- Amlodipine BesylateOxford Pharmaceuticals, LLC
- buspirone hydrochlorideOxford Pharmaceuticals, LLC
- CarisoprodolOxford Pharmaceuticals, LLC
- DipyridamoleOxford Pharmaceuticals, LLC
- GlipizideOxford Pharmaceuticals, LLC
- HydrochlorothiazideOxford Pharmaceuticals, LLC
- Imipramine HydrochlorideOxford Pharmaceuticals, LLC
- methocarbamolOxford Pharmaceuticals, LLC
- paroxetine hydrochlorideOxford Pharmaceuticals, LLC
- PrimidoneOxford Pharmaceuticals, LLC
- Sotalol HydrochlorideOxford Pharmaceuticals, LLC
- SpironolactoneOxford Pharmaceuticals, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.